To evaluate the accuracy of the prediction, samples from cancer patients were collected.
- To evaluate the accuracy of the prediction, samples from cancer patients were collected.
- Title of the poster: Performance of neoantigen prediction for the design of TG4050, a patient specific neoantigen cancer vaccine
The abstract can be downloaded on the AACR website.
- This virus-based therapeutic vaccine encodes neoantigens (patient-specific mutations) identified and selected by NEC's Neoantigen Prediction System.
- For more information, visit NEC at https://www.nec.com.For additional information, please also visit NEC Laboratories Europe GmbH at: http://www.neclab.eu